DNA Methylation as a Therapeutic Target in Hematologic Disorders: Recent Results in Older Patients with Myelodysplasia and Acute Myeloid Leukemia
- 1 August 2004
- journal article
- review article
- Published by Springer Nature in International Journal of Hematology
- Vol. 80 (2) , 128-135
- https://doi.org/10.1532/ijh97.04094
Abstract
DNA methylation provides a major epigenetic code (besides histone modification) of the lineage- and developmentspecific genes (such as regulators of differentiation in the hematopoietic lineages)...Keywords
This publication has 48 references indexed in Scilit:
- CpG Islands in vertebrate genomesPublished by Elsevier ,2004
- Azacitidine Induces Demethylation of the Epstein-Barr Virus Genome in TumorsJournal of Clinical Oncology, 2004
- Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignanciesBlood, 2004
- Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?Leukemia, 2003
- Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo MethylationJournal of Biological Chemistry, 1997
- Pharmacological approach for optimization of the dose schedule of 5-Aza-2’-deoxycytidine (Decitabine) for the therapy of leukemiaLeukemia, 1997
- Treatment with Azacitidine of Patients with End-Stage β-ThalassemiaNew England Journal of Medicine, 1993
- The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup studyAnnals of Hematology, 1992
- DNA methylation levels in acute human leukemiaCancer Letters, 1988
- DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissuesCell, 1980